HYALURONAN INDUCED TARGETING Trademark
Trademark Overview
On Tuesday, November 1, 1994, a trademark application was filed for HYALURONAN INDUCED TARGETING with the United States Patent and Trademark Office. The USPTO has given the HYALURONAN INDUCED TARGETING trademark a serial number of 74593429. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, August 25, 1997. This trademark is owned by HYAL PHARMACEUTICAL CORPORATION. The HYALURONAN INDUCED TARGETING trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
pharmaceutical preparations comprising hyaluronan, adapted for the topical, injectable, and intravenous treatment of the following - cancer, increasing activity of macrophages; reduction of swelling in the brain of person suffering brain trauma; herpes, canker sore, shingles; renal failure, cardiac insufficiency, hypertension, edema; infection, acne, monoucleosis; transplants; inflammation, elminiation of tumor breakdown material (toxins and debris), decreasing side effects, relief of pain; detoxification; bronchodilation; vascular ischemia; HIV (AIDS); diabetes; post-menopause; prevention of topical infection; reduction of swelling; hypertension, cardiac insufficiency; prostaglandin synthesis inhibition; enhancement of oxygenation of tissue by perfusion fluid bathing of the tissue (for transplantation purposes); sub-retinal neovascularization and as an adjunct to the treatment of cancer to prevent metastasis; arthitis or pannus; cancer tumours; inhibiting angiogenesis; controlling ang...
acquisition, development and licensing of intellectual property technology regarding pharmaceutical preparations comprising hyaluronan, adapted for the topical, injectable and intravenous treatment of medical conditions and disease in humans
General Information
| Serial Number | 74593429 |
| Word Mark | HYALURONAN INDUCED TARGETING |
| Filing Date | Tuesday, November 1, 1994 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Monday, August 25, 1997 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Disclaimer with Predetermined Text | "HYALURONAN" |
| Goods and Services | pharmaceutical preparations comprising hyaluronan, adapted for the topical, injectable, and intravenous treatment of the following - cancer, increasing activity of macrophages; reduction of swelling in the brain of person suffering brain trauma; herpes, canker sore, shingles; renal failure, cardiac insufficiency, hypertension, edema; infection, acne, monoucleosis; transplants; inflammation, elminiation of tumor breakdown material (toxins and debris), decreasing side effects, relief of pain; detoxification; bronchodilation; vascular ischemia; HIV (AIDS); diabetes; post-menopause; prevention of topical infection; reduction of swelling; hypertension, cardiac insufficiency; prostaglandin synthesis inhibition; enhancement of oxygenation of tissue by perfusion fluid bathing of the tissue (for transplantation purposes); sub-retinal neovascularization and as an adjunct to the treatment of cancer to prevent metastasis; arthitis or pannus; cancer tumours; inhibiting angiogenesis; controlling angiogenesis; regressing angiogenesis; basal cell carcinoma; actinic keratones; liver spots; squamous cell tumours; metastatic cancer of the breast to the skin; primary and metastatic melanoma of the skin; malignancies and/or tumor of the skin; genital warts (condyloma acuminata); cervical cancer; Human Papilloma Virus (HPV); psoriasis, corns on the feet; and hair loss on the heads of pregnant women; topical treatment of pain in the skin and or exposed tissue; clearing of atherosclerosis; prevention of arterial restenosis after balloon angioplasty; macrophage infilitration |
| Goods and Services | acquisition, development and licensing of intellectual property technology regarding pharmaceutical preparations comprising hyaluronan, adapted for the topical, injectable and intravenous treatment of medical conditions and disease in humans |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Wednesday, August 4, 1999 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Wednesday, August 4, 1999 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | HYAL PHARMACEUTICAL CORPORATION |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Toronto, Ontario M5C 1B5
CA |
Trademark Events
| Event Date | Event Description |
| Monday, August 25, 1997 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, January 29, 1997 | INQUIRY AS TO SUSPENSION MAILED |
| Thursday, June 6, 1996 | UNRESPONSIVE/DUPLICATE PAPER RECEIVED |
| Tuesday, June 4, 1996 | INQUIRY AS TO SUSPENSION MAILED |
| Saturday, January 6, 1996 | LETTER OF SUSPENSION MAILED |
| Monday, October 16, 1995 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 18, 1995 | NON-FINAL ACTION MAILED |
| Friday, March 17, 1995 | ASSIGNED TO EXAMINER |
